A merger of the German Bayer AG and Monsanto American.
German hiscompany Bayer AG concluded the merger with the American Monsanto Co., a world leader in plant biotechnology, reports Rus.Media.
“The Company’s shareholders will receive $128 per share. In accordance with the requirements of the conditional approval the U.S. Department of justice, the integration of the Company into the structure of the Bayer will take place after the completion of the transfer of assets of BASF in the framework of individual business areas. It is expected that the integration process will begin in approximately 2 months.”
Board member Bayer Liam Kanden will head the combined division of Crop Science, as soon as integration. By this time, Monsanto will conduct its activities independently from Bayer.
German Bayer announced the merger with Monsanto, the world leader in plant biotechnology, the transaction volume of $66 billion in September 2016.
The combined company will retain the name Bayer and refuse the mention of Monsanto. The brands of products Monsanto will retain its name and will become part of the portfolio of Bayer.
The German company expects that the transaction will have a positive impact on its net earnings per share in 2019. The proceeds from the planned placement of shares and bonds Bayer plans to direct for payment of the syndicated loan that the company took to pay Monsanto.
Business Agreement Agribusiness Monsanto Bayer AG